HOME › DRUGS › MEMANTINE
ACTIVE SUBSTANCE / INN

MEMANTINE

Brand name(s): Axura, Memantine Accord, Marixino (previously Maruxa), Memantine Mylan, Ebixa, Memantine LEK, Nemdatine, Memantine ratiopharm, Memantine FGK
EMA LISTED
APPLICATION WITHDRAWN
WITHDRAWN
AUTHORISED
Alzheimer Disease
ACTIVE SUBSTANCE
Memantine
REGULATORS
EMA
SPONSORS / MAH
Ratiopharm GmbH, Pharmathen S.A., H. Lundbeck A/S
TOTAL APPLICATIONS
9
EMA AUTHORISATIONS
PRODUCT NAMEHOLDERSTATUSDATEINDICATION
Memantine MylanMylan Pharmaceuticals LimitedAuthorised21/04/2013Alzheimer Disease
Memantine AccordAccord Healthcare S.L.U.Authorised03/12/2013Alzheimer Disease
AxuraMerz Pharmaceuticals GmbHAuthorised17/05/2002Alzheimer Disease
Memantine LEKPharmathen S.A.Withdrawn21/04/2013Alzheimer Disease
NemdatineActavis Group PTC ehfAuthorised22/04/2013Alzheimer Disease
Memantine ratiopharmRatiopharm GmbHAuthorised12/06/2013Alzheimer Disease
EbixaH. Lundbeck A/SAuthorised15/05/2002Alzheimer Disease
Marixino (previously Maruxa)KRKA, d.d.Authorised28/04/2013Alzheimer Disease
Memantine FGKFGK Representative Service GmbHApplication withdrawnAlzheimer Disease

FULL INTELLIGENCE ON MEMANTINE

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →